Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorent

Showing results (351-360 of 368) with videos related to

Pageof 37
Sort By:
ERJ Open Research|March 6, 2024
Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international studyYin Ting Lam, Jean-François Papon, Mihaela Alexandru, et al.
The European Respiratory Journal|May 22, 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE studyKai Xian Thng, Pei Yee Tiew, Micheál Mac Aogáin, et al.
Nature|August 3, 2022
Teixobactin kills bacteria by a two-pronged attack on the cell envelopeRhythm Shukla, Francesca Lavore, Sourav Maity, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Anthony De Soyza, Katerina Dimakou, et al.
ERJ Open Research|June 24, 2025
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohortKewei Zhang, Avni Kant, Mieke Boon, et al.
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
Thorax|March 23, 2025
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Jennifer Pollock, Eva Polverino, Raja Dhar, et al.
The European Respiratory Journal|April 12, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Stefano Aliberti, Felix C Ringshausen, Raja Dhar, et al.
Pageof 37

Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
ERJ Open Research|March 6, 2024
Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international studyYin Ting Lam, Jean-François Papon, Mihaela Alexandru, et al.
The European Respiratory Journal|May 22, 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE studyKai Xian Thng, Pei Yee Tiew, Micheál Mac Aogáin, et al.
Nature|August 3, 2022
Teixobactin kills bacteria by a two-pronged attack on the cell envelopeRhythm Shukla, Francesca Lavore, Sourav Maity, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Anthony De Soyza, Katerina Dimakou, et al.
ERJ Open Research|June 24, 2025
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohortKewei Zhang, Avni Kant, Mieke Boon, et al.
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
Thorax|March 23, 2025
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Jennifer Pollock, Eva Polverino, Raja Dhar, et al.
The European Respiratory Journal|April 12, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Stefano Aliberti, Felix C Ringshausen, Raja Dhar, et al.
Pageof 37